{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T13:06:34Z","timestamp":1791551194607,"version":"4.3.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11845-025-04221-x","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T09:04:08Z","timestamp":1764925448000},"page":"511-520","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The utility of eGFR difference (eGFRCystatin C \u2013 eGFRCreatinine) in the diagnosis, prognosis, and management of chronic kidney disease: a comprehensive review"],"prefix":"10.1007","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1967-4470","authenticated-orcid":false,"given":"Gerry George","family":"Mathew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"issue":"5","key":"4221_CR1","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.kint.2019.07.012","volume":"96","author":"KJ Jager","year":"2019","unstructured":"Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C (2019) A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int 96(5):1048\u20131050","journal-title":"Kidney Int"},{"issue":"11","key":"4221_CR2","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","volume":"158","author":"PE Stevens","year":"2013","unstructured":"Stevens PE, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members (2013) Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 158(11):825\u2013830","journal-title":"Ann Intern Med"},{"issue":"4","key":"4221_CR3","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1159\/000469669","volume":"136","author":"P Delanaye","year":"2017","unstructured":"Delanaye P, Cavalier E, Pottel H (2017) Serum creatinine: not so simple! Nephron 136(4):302\u2013308","journal-title":"Nephron"},{"issue":"10","key":"4221_CR4","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJMoa1214234","volume":"369","author":"MG Shlipak","year":"2013","unstructured":"Shlipak MG, Matsushita K, \u00c4rnl\u00f6v J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, Levey AS, Gansevoort RT, CKD Prognosis Consortium (2013) Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 369(10):932\u2013943","journal-title":"N Engl J Med"},{"issue":"6","key":"4221_CR5","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/ki.2008.638","volume":"75","author":"LA Stevens","year":"2009","unstructured":"Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, Froissart M, Kusek JW, Zhang YL, Coresh J, Levey AS (2009) Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 75(6):652\u2013660","journal-title":"Kidney Int"},{"issue":"7","key":"4221_CR6","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1373\/clinchem.2013.220707","volume":"60","author":"A Grubb","year":"2014","unstructured":"Grubb A, Horio M, Hansson LO, Bj\u00f6rk J et al (2014) Generation of a new cystatin C-based estimating equation for glomerular filtration rate by use of 7 assays standardized to the international calibrator. Clin Chem 60(7):974\u201386","journal-title":"Clin Chem"},{"issue":"6","key":"4221_CR7","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1053\/j.ajkd.2020.05.017","volume":"76","author":"OA Potok","year":"2020","unstructured":"Potok OA, Ix JH, Shlipak MG et al (2020) The difference between cystatin C- and creatinine-based estimated GFR and associations with frailty and adverse outcomes: a cohort analysis of the Systolic Blood Pressure Intervention Trial (SPRINT). Am J Kidney Dis 76(6):765\u2013774","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"4221_CR8","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1681\/ASN.2009050546","volume":"20","author":"MG Shlipak","year":"2009","unstructured":"Shlipak MG, Katz R, Kestenbaum B, Siscovick D, Fried L, Newman A, Rifkin D, Sarnak MJ (2009) Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol 20(12):2625\u20132630","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"4221_CR9","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1681\/ASN.2010050479","volume":"22","author":"UD Mathisen","year":"2011","unstructured":"Mathisen UD, Melsom T, Ingebretsen OC, Jenssen T, Nj\u00f8lstad I, Solbu MD, Toft I, Eriksen BO (2011) Estimated GFR associates with cardiovascular risk factors independently of measured GFR. J Am Soc Nephrol 22(5):927\u2013937","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"4221_CR10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jacc.2012.03.040","volume":"60","author":"JH Ix","year":"2012","unstructured":"Ix JH, Katz R, Kestenbaum BR et al (2012) Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular health Study). J Am Coll Cardiol 60(3):200\u2013207","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"4221_CR11","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1152\/physrev.2000.80.3.1107","volume":"80","author":"M Wyss","year":"2000","unstructured":"Wyss M, Kaddurah-Daouk R (2000) Creatine and creatinine metabolism. Physiol Rev 80(3):1107\u20131213","journal-title":"Physiol Rev"},{"key":"4221_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1146\/annurev.me.39.020188.002341","volume":"39","author":"AS Levey","year":"1988","unstructured":"Levey AS, Perrone RD, Madias NE (1988) Serum creatinine and renal function. Annu Rev Med 39:465\u2013490","journal-title":"Annu Rev Med"},{"issue":"3","key":"4221_CR13","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/ajcn\/37.3.478","volume":"37","author":"SB Heymsfield","year":"1983","unstructured":"Heymsfield SB, Arteaga C, McManus C, Smith J, Moffitt S (1983) Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method. Am J Clin Nutr 37(3):478\u2013494","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"4221_CR14","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1097\/CCM.0000000000002013","volume":"45","author":"KB Kashani","year":"2017","unstructured":"Kashani KB, Frazee EN, Kukr\u00e1lov\u00e1 L, Sarvottam K, Herasevich V, Young PM, Kashyap R, Lieske JC (2017) Evaluating muscle mass by using markers of kidney function: development of the sarcopenia index. Crit Care Med 45(1):e23\u2013e29","journal-title":"Crit Care Med"},{"issue":"2","key":"4221_CR15","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/0006-291X(84)91302-0","volume":"120","author":"AJ Barrett","year":"1984","unstructured":"Barrett AJ, Davies ME, Grubb A (1984) The place of human gamma-trace (cystatin C) amongst the cysteine proteinase inhibitors. Biochem Biophys Res Commun 120(2):631\u2013636","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"4221_CR16","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3109\/00365519609088795","volume":"56","author":"O Tenstad","year":"1996","unstructured":"Tenstad O, Roald AB, Grubb A, Aukland K (1996) Renal handling of radiolabelled human cystatin C in the rat. Scand J Clin Lab Invest 56(5):409\u2013414","journal-title":"Scand J Clin Lab Invest"},{"issue":"4","key":"4221_CR17","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1111\/j.1523-1755.2004.00517.x","volume":"65","author":"EL Knight","year":"2004","unstructured":"Knight EL, Verhave JC, Spiegelman D et al (2004) Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 65(4):1416\u20131421","journal-title":"Kidney Int"},{"issue":"5\u20136","key":"4221_CR18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.clinbiochem.2006.10.026","volume":"40","author":"JF Roos","year":"2007","unstructured":"Roos JF, Doust J, Tett SE, Kirkpatrick CM (2007) Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children\u2014a meta-analysis. Clin Biochem 40(5\u20136):383\u2013391","journal-title":"Clin Biochem"},{"issue":"2","key":"4221_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1053\/ajkd.2002.34487","volume":"40","author":"VR Dharnidharka","year":"2002","unstructured":"Dharnidharka VR, Kwon C, Stevens G (2002) Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 40(2):221\u2013226","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"4221_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1114248","volume":"367","author":"LA Inker","year":"2012","unstructured":"Inker LA, Schmid CH, Tighiouart H et al (2012) Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367(1):20\u201329","journal-title":"N Engl J Med"},{"issue":"2","key":"4221_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1161\/CIRCULATIONAHA.106.644286","volume":"115","author":"JH Ix","year":"2007","unstructured":"Ix JH, Shlipak MG, Chertow GM, Whooley MA (2007) Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the heart and soul study. Circulation 115(2):173\u2013179","journal-title":"Circulation"},{"issue":"20","key":"4221_CR22","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1001\/archinte.167.20.2213","volume":"167","author":"MC Odden","year":"2007","unstructured":"Odden MC, Scherzer R, Bacchetti P et al (2007) Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study. Arch Intern Med 167(20):2213\u20132219","journal-title":"Arch Intern Med"},{"issue":"10","key":"4221_CR23","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1111\/j.1532-5415.2009.02459.x","volume":"57","author":"TK Malmstrom","year":"2009","unstructured":"Malmstrom TK, Miller DK, Coats MA, Jackson P, Brose A, Morley JE (2009) Informant-based dementia screening in a population-based sample. J Am Geriatr Soc 57(10):1892\u20131896","journal-title":"J Am Geriatr Soc"},{"key":"4221_CR24","first-page":"1407","volume":"8","author":"E Marini","year":"2013","unstructured":"Marini E, Sergi G, Succa V et al (2013) The potential of classic and novel bioelectrical impedance vector analysis for the assessment of sarcopenia and sarcopenic obesity. Clin Interv Aging 8:1407\u20131415","journal-title":"Clin Interv Aging"},{"issue":"6","key":"4221_CR25","doi-asserted-by":"publisher","first-page":"526e9","DOI":"10.1016\/j.amjmed.2005.10.049","volume":"119","author":"LA Schaap","year":"2006","unstructured":"Schaap LA, Pluijm SM, Deeg DJ, Visser M (2006) Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med 119(6):526e9\u201352617","journal-title":"Am J Med"},{"issue":"8","key":"4221_CR26","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jamainternmed.2018.2607","volume":"178","author":"MC Foster","year":"2018","unstructured":"Foster MC, Ix JH, Tighiouart H et al (2018) Effect of a nutritional supplement on kidney function decline in elderly people: a randomized clinical trial. JAMA Intern Med 178(8):1049\u20131057","journal-title":"JAMA Intern Med"},{"issue":"8","key":"4221_CR27","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1080\/00365519950185076","volume":"59","author":"E Vinge","year":"1999","unstructured":"Vinge E, Linderg\u00e5rd B, Nilsson-Ehle P, Grubb A (1999) Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults. Scand J Clin Lab Invest 59(8):587\u2013592","journal-title":"Scand J Clin Lab Invest"},{"issue":"3","key":"4221_CR28","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1053\/j.ajkd.2007.11.019","volume":"51","author":"A K\u00f6ttgen","year":"2008","unstructured":"K\u00f6ttgen A, Selvin E, Stevens LA et al (2008) Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 51(3):385\u2013394","journal-title":"Am J Kidney Dis"},{"key":"4221_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2021.08.036","volume":"335","author":"H Kim","year":"2021","unstructured":"Kim H, Park JT, Lee J, Jung JY, Lee KB, Kim YH, Yoo TH, Kang SW, Choi KH, Oh KH, Ahn C, Han SH, KNOW-CKD investigators (2021) The difference between cystatin C- and creatinine-based eGFR is associated with adverse cardiovascular outcome in patients with chronic kidney disease. Atherosclerosis 335:53\u201361","journal-title":"Atherosclerosis"},{"issue":"10","key":"4221_CR30","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1093\/ndt\/gft226","volume":"28","author":"M Evans","year":"2013","unstructured":"Evans M, van Stralen KJ, Sch\u00f6n S et al (2013) Glomerular filtration rate-estimating equations for patients with advanced chronic kidney disease. Nephrol Dial Transplant 28(10):2518\u20132526","journal-title":"Nephrol Dial Transplant"},{"issue":"5 Suppl","key":"4221_CR31","doi-asserted-by":"publisher","first-page":"990S","DOI":"10.1093\/jn\/127.5.990S","volume":"127","author":"IH Rosenberg","year":"1997","unstructured":"Rosenberg IH (1997) Sarcopenia: origins and clinical relevance. J Nutr 127(5 Suppl):990S\u2013991S","journal-title":"J Nutr"},{"issue":"4","key":"4221_CR32","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/sj.ki.5002585","volume":"73","author":"D Fouque","year":"2008","unstructured":"Fouque D, Kalantar-Zadeh K, Kopple J et al (2008) A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 73(4):391\u2013398","journal-title":"Kidney Int"},{"issue":"13","key":"4221_CR33","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351(13):1296\u20131305","journal-title":"N Engl J Med"},{"issue":"6","key":"4221_CR34","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1001\/archinte.164.6.659","volume":"164","author":"DS Keith","year":"2004","unstructured":"Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH (2004) Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164(6):659\u2013663","journal-title":"Arch Intern Med"},{"issue":"1","key":"4221_CR35","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1681\/ASN.2005050545","volume":"17","author":"MG Shlipak","year":"2006","unstructured":"Shlipak MG, Wassel Fyr CL, Chertow GM et al (2006) Cystatin C and mortality risk in the elderly: the health, aging, and body composition study. J Am Soc Nephrol 17(1):254\u2013261","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"4221_CR36","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.kint.2016.09.003","volume":"91","author":"CY Hsu","year":"2017","unstructured":"Hsu CY, Xie D, Waikar SS et al (2017) Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression. Kidney Int 91(1):196\u2013203","journal-title":"Kidney Int"},{"issue":"19","key":"4221_CR37","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","volume":"288","author":"JT Wright Jr","year":"2002","unstructured":"Wright JT Jr, Bakris G, Greene T et al (2002) Effect of blood pressure Lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 288(19):2421\u20132431","journal-title":"JAMA"},{"issue":"14","key":"4221_CR38","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1001\/jama.293.14.1737","volume":"293","author":"MG Shlipak","year":"2005","unstructured":"Shlipak MG, Fried LF, Cushman M et al (2005) Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 293(14):1737\u20131745","journal-title":"JAMA"},{"issue":"9","key":"4221_CR39","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/aje\/kwf113","volume":"156","author":"DE Bild","year":"2002","unstructured":"Bild DE, Bluemke DA, Burke GL et al (2002) Multi-Ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 156(9):871\u2013881","journal-title":"Am J Epidemiol"},{"issue":"4","key":"4221_CR40","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3904\/kjim.2016.015","volume":"31","author":"KM Kim","year":"2016","unstructured":"Kim KM, Jang HC, Lim S (2016) Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing sarcopenia. Korean J Intern Med 31(4):643\u2013650","journal-title":"Korean J Intern Med"},{"issue":"6","key":"4221_CR41","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0894-0959.2004.17606.x","volume":"17","author":"K Kalantar-Zadeh","year":"2004","unstructured":"Kalantar-Zadeh K, Mehrotra R, Fouque D, Kopple JD (2004) Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure. Semin Dial 17(6):455\u2013465","journal-title":"Semin Dial"},{"issue":"11","key":"4221_CR42","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/gerona\/glp097","volume":"64","author":"LA Schaap","year":"2009","unstructured":"Schaap LA, Pluijm SM, Deeg DJ et al (2009) Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol Biol Sci Med Sci 64(11):1183\u20131189","journal-title":"J Gerontol Biol Sci Med Sci"},{"issue":"6","key":"4221_CR43","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1093\/ageing\/afu115","volume":"43","author":"AJ Cruz-Jentoft","year":"2014","unstructured":"Cruz-Jentoft AJ, Landi F, Schneider SM et al (2014) Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 43(6):748\u2013759","journal-title":"Age Ageing"},{"issue":"3","key":"4221_CR44","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/gerona\/59.3.M242","volume":"59","author":"M Cesari","year":"2004","unstructured":"Cesari M, Penninx BW, Pahor M et al (2004) Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol Biol Sci Med Sci 59(3):242\u2013248","journal-title":"J Gerontol Biol Sci Med Sci"},{"issue":"3","key":"4221_CR45","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","volume":"56","author":"LP Fried","year":"2001","unstructured":"Fried LP, Tangen CM, Walston J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol Biol Sci Med Sci 56(3):M146\u2013156","journal-title":"J Gerontol Biol Sci Med Sci"},{"issue":"19","key":"4221_CR46","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J et al (2021) New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med 385(19):1737\u20131749","journal-title":"N Engl J Med"},{"issue":"3","key":"4221_CR47","doi-asserted-by":"publisher","first-page":"297","DOI":"10.5858\/2005-129-297-CMSOTA","volume":"129","author":"WG Miller","year":"2005","unstructured":"Miller WG, Myers GL, Ashwood ER et al (2005) Creatinine measurement: state of the art in accuracy and interlaboratory harmonization. Arch Pathol Lab Med 129(3):297\u2013304","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"4221_CR48","first-page":"1","volume":"3","author":"A Levin","year":"2013","unstructured":"Levin A, Stevens PE, Bilous RW et al (2013) Kidney disease: improving global outcomes (KDIGO) CKD work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3(1):1\u2013150","journal-title":"Kidney Int Suppl"},{"issue":"11","key":"4221_CR49","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1681\/ASN.2007020221","volume":"18","author":"KL Johansen","year":"2007","unstructured":"Johansen KL, Chertow GM, Jin C, Kutner NG (2007) Significance of frailty among dialysis patients. J Am Soc Nephrol 18(11):2960\u20132967","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"4221_CR50","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.2215\/CJN.06870909","volume":"5","author":"WM Michels","year":"2010","unstructured":"Michels WM, Grootendorst DC, Verduijn M et al (2010) Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol 5(6):1003\u20131009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"4221_CR51","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1001\/jama.2015.18202","volume":"315","author":"N Tangri","year":"2016","unstructured":"Tangri N, Grams ME, Levey AS et al (2016) Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis. JAMA 315(2):164\u2013174","journal-title":"JAMA"},{"issue":"18","key":"4221_CR52","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1001\/jama.2012.3954","volume":"307","author":"K Matsushita","year":"2012","unstructured":"Matsushita K, Mahmoodi BK, Woodward M et al (2012) Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 307(18):1941\u20131951","journal-title":"JAMA"},{"issue":"12","key":"4221_CR53","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1093\/ndt\/gfu255","volume":"29","author":"R Agarwal","year":"2014","unstructured":"Agarwal R, Duffin KL, Laska DA et al (2014) A prospective study of multiple protein biomarkers to predict progression in diabetic chronic kidney disease. Nephrol Dial Transplant 29(12):2293\u20132302","journal-title":"Nephrol Dial Transplant"},{"issue":"24","key":"4221_CR54","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1001\/jama.2014.6634","volume":"311","author":"J Coresh","year":"2014","unstructured":"Coresh J, Turin TC, Matsushita K et al (2014) Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 311(24):2518\u20132531","journal-title":"JAMA"},{"issue":"2","key":"4221_CR55","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1053\/j.ajkd.2010.08.016","volume":"57","author":"LC Plantinga","year":"2011","unstructured":"Plantinga LC, Johansen KL, Crews DC et al (2011) Association of CKD with disability in the United States. Am J Kidney Dis 57(2):212\u2013227","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"4221_CR56","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Mu\u00f1oz A, Schneider MF et al (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20(3):629\u2013637","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"4221_CR57","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/j.1524-4733.2009.00668.x","volume":"13","author":"K Howard","year":"2010","unstructured":"Howard K, White S, Salkeld G et al (2010) Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modelled analysis. Value Health 13(2):196\u2013208","journal-title":"Value Health"},{"issue":"3","key":"4221_CR58","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/MNH.0000000000000115","volume":"24","author":"TW Ferguson","year":"2015","unstructured":"Ferguson TW, Komenda P, Tangri N (2015) Cystatin C as a biomarker for estimating glomerular filtration rate. Curr Opin Nephrol Hypertens 24(3):295\u2013300","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"10","key":"4221_CR59","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1093\/ndt\/gfg349","volume":"18","author":"FJ Hoek","year":"2003","unstructured":"Hoek FJ, Kemperman FA, Krediet RT (2003) A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 18(10):2024\u20132031","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"4221_CR60","first-page":"83","volume":"4","author":"JR Delanghe","year":"2011","unstructured":"Delanghe JR, Speeckaert MM (2011) Creatinine determination according to Jaff\u00e9\u2014what does it stand for? NDT Plus 4(2):83\u201386","journal-title":"NDT Plus"},{"issue":"2 Suppl 1","key":"4221_CR61","first-page":"S1","volume":"39","author":"National Kidney Foundation","year":"2002","unstructured":"National Kidney Foundation (2002) K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1-266","journal-title":"Am J Kidney Dis"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-025-04221-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-025-04221-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-025-04221-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T10:02:17Z","timestamp":1772877737000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-025-04221-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4221"],"URL":"https:\/\/doi.org\/10.1007\/s11845-025-04221-x","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author has no financial disclosures to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial disclosures"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"There was no requirement for informed consent from patients since it was a manuscript by the physician based on current scientific evidence.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent to participate"}},{"value":"There are no conflicts of interest related to the study design or its results.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}